These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 27565348)
1. HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis. Kessl JJ; Kutluay SB; Townsend D; Rebensburg S; Slaughter A; Larue RC; Shkriabai N; Bakouche N; Fuchs JR; Bieniasz PD; Kvaratskhelia M Cell; 2016 Aug; 166(5):1257-1268.e12. PubMed ID: 27565348 [TBL] [Abstract][Full Text] [Related]
2. Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis. Elliott JL; Eschbach JE; Koneru PC; Li W; Puray-Chavez M; Townsend D; Lawson DQ; Engelman AN; Kvaratskhelia M; Kutluay SB Elife; 2020 Sep; 9():. PubMed ID: 32960169 [TBL] [Abstract][Full Text] [Related]
3. Distribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: a Role for Integrase in Maturation. Fontana J; Jurado KA; Cheng N; Ly NL; Fuchs JR; Gorelick RJ; Engelman AN; Steven AC J Virol; 2015 Oct; 89(19):9765-80. PubMed ID: 26178982 [TBL] [Abstract][Full Text] [Related]
4. Going beyond Integration: The Emerging Role of HIV-1 Integrase in Virion Morphogenesis. Elliott JL; Kutluay SB Viruses; 2020 Sep; 12(9):. PubMed ID: 32916894 [TBL] [Abstract][Full Text] [Related]
5. The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome. van Bel N; van der Velden Y; Bonnard D; Le Rouzic E; Das AT; Benarous R; Berkhout B PLoS One; 2014; 9(7):e103552. PubMed ID: 25072705 [TBL] [Abstract][Full Text] [Related]
6. Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells. Madison MK; Lawson DQ; Elliott J; Ozantürk AN; Koneru PC; Townsend D; Errando M; Kvaratskhelia M; Kutluay SB J Virol; 2017 Sep; 91(17):. PubMed ID: 28615207 [TBL] [Abstract][Full Text] [Related]
8. The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity. Amadori C; van der Velden YU; Bonnard D; Orlov I; van Bel N; Le Rouzic E; Miralles L; Brias J; Chevreuil F; Spehner D; Chasset S; Ledoussal B; Mayr L; Moreau F; García F; Gatell J; Zamborlini A; Emiliani S; Ruff M; Klaholz BP; Moog C; Berkhout B; Plana M; Benarous R Retrovirology; 2017 Nov; 14(1):50. PubMed ID: 29121950 [TBL] [Abstract][Full Text] [Related]
9. HIV type 1 integrase inhibitors: from basic research to clinical implications. Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719 [TBL] [Abstract][Full Text] [Related]
10. Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells. Balakrishnan M; Yant SR; Tsai L; O'Sullivan C; Bam RA; Tsai A; Niedziela-Majka A; Stray KM; Sakowicz R; Cihlar T PLoS One; 2013; 8(9):e74163. PubMed ID: 24040198 [TBL] [Abstract][Full Text] [Related]
12. Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer. Sun J; Patel K; Hume J; Pigza JA; Donahue MG; Kessl JJ J Biol Chem; 2021; 296():100363. PubMed ID: 33539919 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 integrase binding to genomic RNA 5'-UTR induces local structural changes in vitro and in virio. Liu S; Koneru PC; Li W; Pathirage C; Engelman AN; Kvaratskhelia M; Musier-Forsyth K Retrovirology; 2021 Nov; 18(1):37. PubMed ID: 34809662 [TBL] [Abstract][Full Text] [Related]
14. HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors. Koneru PC; Francis AC; Deng N; Rebensburg SV; Hoyte AC; Lindenberger J; Adu-Ampratwum D; Larue RC; Wempe MF; Engelman AN; Lyumkis D; Fuchs JR; Levy RM; Melikyan GB; Kvaratskhelia M Elife; 2019 May; 8():. PubMed ID: 31120420 [TBL] [Abstract][Full Text] [Related]
15. A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor. Nakamura T; Nakamura T; Amano M; Miyakawa T; Yamagata Y; Matsuoka M; Nakata H J Virol; 2020 Sep; 94(19):. PubMed ID: 32611758 [TBL] [Abstract][Full Text] [Related]
16. [Universal modular system for in vitro screening of potential inhibitors of HIV-1 replication]. Prokof'eva MM; Orlova NN; Gornostaeva AS; Shul'gin AA; Nikitenko NA; Senchenko VN; Lebedev TD; Spirin PV; Riechen K; Fehse B; Stocking C; Prasolov VS Mol Biol (Mosk); 2014; 48(2):344-8. PubMed ID: 25850304 [TBL] [Abstract][Full Text] [Related]
17. Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase. Gupta K; Turkki V; Sherrill-Mix S; Hwang Y; Eilers G; Taylor L; McDanal C; Wang P; Temelkoff D; Nolte RT; Velthuisen E; Jeffrey J; Van Duyne GD; Bushman FD PLoS Biol; 2016 Dec; 14(12):e1002584. PubMed ID: 27935939 [TBL] [Abstract][Full Text] [Related]
18. Resistance to pyridine-based inhibitor KF116 reveals an unexpected role of integrase in HIV-1 Gag-Pol polyprotein proteolytic processing. Hoyte AC; Jamin AV; Koneru PC; Kobe MJ; Larue RC; Fuchs JR; Engelman AN; Kvaratskhelia M J Biol Chem; 2017 Dec; 292(48):19814-19825. PubMed ID: 28972144 [TBL] [Abstract][Full Text] [Related]
19. Resistance to inhibitors of the human immunodeficiency virus type 1 integration. Hazuda DJ Braz J Infect Dis; 2010; 14(5):513-8. PubMed ID: 21221483 [TBL] [Abstract][Full Text] [Related]
20. Biochemical screening assays to identify HIV-1 integrase inhibitors. Clynhens M; Smets A; Vereycken I; Van Loock M; Clayton R; Meersseman G; Goethals O Methods Mol Biol; 2013; 1030():25-36. PubMed ID: 23821258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]